Talks – ADTC

Speaker

Affiliations

Categories

All (22)

AD Cascade (1)

AD Mechanisms (1)

AD Models (1)

AD Pathology (1)

AD Time Project (1)

Alzheimer's Disease (7)

Behavioral Analysis (1)

Beta-amyloid (1)

Biomarkers (1)

Brain Aging (1)

Clinical Research (1)

Clinical Trial (1)

Dementia (1)

Dementia Risk (1)

Early AD (1)

Early Pathology (1)

Endosomal Function (1)

Exercise (1)

Inflammation (1)

Lifestyle Factors (1)

Microglia (1)

NAD+ Metabolism (1)

Neural Models (1)

Neuroinflammation (1)

Neuronal Hyperexcitability (1)

Plasma Treatment (1)

Protein Changes (1)

Protein Interactions (1)

Public Health (1)

Tau Pathology (1)

Temporal Dynamics (1)

Translational Medicine (1)

Translational Research (1)

Keynotes

Cryo-EM structures of tau filaments and their impact on Alzheimer’s disease

Alzheimer's Disease

The assembly of a small number of proteins into abundant amyloid filaments defines most human neurodegenerative diseases, including Alzheimer’s and…

Day	2
Time	09:00-09:40

Insights from new models for tauopathy research and translation

Translational Research

Human-relevant mouse and cell models for studying tau pathogenesis in AD and FTD-tau have recently been developed. Insights into pathogenic…

Day	3
Time	09:00-09:40

Talks

Anatomical units of space, time and memory

Alzheimer's Disease

Space and time are essential elements of episodic or conscious memory, the type of memory that is…

Day	1
Time	14:00-14:30

Functional units of space, time and memory

Alzheimer's Disease

The hippocampal formation contains networks of neurons that encode our spatial surroundings, as…

Day	1
Time	14:40-15:10

Imaging the anatomical and structural units of memory

Alzheimer's Disease

Content TBA

Christian Döller

Day	1
Time	15:20-15:50

Neuron-selective vulnerability in prodromal AD

Alzheimer's Disease

The major population of principal neurons in layer II of the entorhinal cortex expresses…

Asgeir Kobro-Flatmoen

Day	1
Time	16:20-16:50

The clinical presentation and diagnosis of AD

Alzheimer's Disease

AD diagnosis relies on clinical evaluation, neuropsychological testing, and biomarkers such as…

Gøril Rolfseng Grøntvedt

Day	1
Time	18:30-19:00

The Norwegian Health Association: User engagement in research

Alzheimer's Disease

The Norwegian Health Association has, as the national user organisation for persons with dementia…

Anne Rita Øksengård

Day	1
Time	19:10-19:40

Sequence of protein changes in AD

Protein Changes

Alzheimer’s disease is histopathologically characterized by the deposition of amyloid plaques and…

Day	2
Time	09:50-10:20

Certain subtypes of entorhinal neurons are particularly prone to the development of pathological tau species

In recent years the development of genetic tools specific to particular neuronal subtypes has…

Day	2
Time	10:30-11:00

Early/initiating pathological interactions, Aβ, p-tau and ApoE

Early Pathology

Protein Interactions

Content TBA

Day	2
Time	11:30-12:00

Endosomal dysfunction triggers intraneuronal beta-amyloid in late-onset AD

Endosomal Function

Late-onset Alzheimer’s disease (LOAD) is linked to aging and genetic risk factors like Bin1 and…

Claudia Almeida

Day	2
Time	12:10-12:40

Microglial changes in early stages of AD

The risk to develop sporadic Alzheimer’s disease can be linked to SNPs in innate immunity genes…

Kristine Freude

Day	2
Time	14:00-14:30

Lifestyle and Dementia Risk: Does It Apply to Alzheimer’s?

Lifestyle Factors

Research suggests that over 40% of dementia cases could be prevented or delayed by addressing 14…

Day	2
Time	14:40-15:10

The vicious circle between neuronal hyperexcitability and AD

Neuronal Hyperexcitability

Neuronal hyperexcitability and hyperactivity are features that can be considered part of…

Day	2
Time	16:30-17:00

Exercised Plasma to Treat Alzheimer’s Disease – The ExPlas Study

Plasma Treatment

ExPlas is a first-in-human study examining the feasibility and potential impact of administering…

Day	2
Time	17:10-17:40

Roles of inflammation in Alzheimer’s disease and dementia

Content TBA

Day	2
Time	18:10-18:40

Ethologically relevant phenotyping of cognitive impairments in AD model mice

Behavioral Analysis

Content TBA

Day	2
Time	18:50-19:20

Fine-tuning the NAD+-mitophagy axis in healthy brain ageing

NAD+ Metabolism

NAD+ plays a fundamental role in life and health, including in brain resilience. Preclinical and…

Day	2
Time	19:30-20:00

Alzheimer’s disease non-core brain pathologies and pathomechanisms

Neuroinflammation

Content TBA

Day	3
Time	09:50-10:20

The Trønderbrain project – Next-generation translational medicine

Translational Medicine

Clinical Research

The Trønderbrain project is a collaborative research initiative established in 2003 by St. Olavs…

Katja Scheffler

Day	3
Time	11:00-11:30

Memory, time and space in the human brain – impact of early Alzheimer’s disease

AD Time Project

Temporal Dynamics

The hippocampal region is one of the first areas to be affected by Alzhimer’s pathology. Neural…

Day	3
Time	11:40-12:10